Advanced Search
Submit Manuscript Volume 30, No 9, Sep 2020
ISSN: 1001-0602
EISSN: 1748-7838 2018
impact factor 17.848*
(Clarivate Analytics, 2019)
Volume 30 Issue 9, September 2020: 817-818
Serosurvey of SARS-CoV-2 among hospital visitors in China
Wenhua Liang1 , Yongping Lin2 , Jianping Bi3 , Jianfu Li1 , Ying Liang2 , Sook-San Wong1 , Mark Zanin1,4 , Zifeng Yang1 , Caichen Li1 , Ran Zhong1 , Guowu Jiang5 , Guang Han3,* , Desheng Hu3,* , Jianxing He1,6,* , Nanshan Zhong1
1Department of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University, China State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, Guangzhou, Guangdong 510000, ChinaDear Editor,
In China, the epidemic of COVID-19 has been temporarily brought under control due to strong measures, while there are few new cases except some imported ones (https://static.wecity.qq.com/wuhan-haiwai-pre/dist/index.html#/). The PCR-based test result combined with clinical symptoms has widely been used for the detection and confirmation of COVID-19.1 However, the prevalence of asymptomatic or subclinical SARS-CoV-2 infection in China remained unknown.
https://doi.org/10.1038/s41422-020-0371-0